IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,138,859 | -7.7% | 429,788 | +1.9% | 0.00% | 0.0% |
| Q2 2023 | $4,486,367 | -26.8% | 421,651 | -27.7% | 0.00% | -25.0% |
| Q1 2023 | $6,132,392 | +0.7% | 582,927 | +18.6% | 0.00% | -20.0% |
| Q4 2022 | $6,088,606 | -10.4% | 491,413 | -25.1% | 0.01% | 0.0% |
| Q3 2022 | $6,796,000 | +45.7% | 655,994 | +62.1% | 0.01% | +66.7% |
| Q2 2022 | $4,665,000 | +293.0% | 404,623 | +328.8% | 0.00% | +200.0% |
| Q1 2022 | $1,187,000 | -75.6% | 94,371 | -77.3% | 0.00% | -66.7% |
| Q4 2021 | $4,856,000 | +13.3% | 416,483 | +26.9% | 0.00% | 0.0% |
| Q3 2021 | $4,286,000 | -38.1% | 328,147 | -39.0% | 0.00% | -25.0% |
| Q2 2021 | $6,928,000 | +42.1% | 538,191 | +23.4% | 0.00% | +33.3% |
| Q1 2021 | $4,876,000 | +307.7% | 436,107 | +315.5% | 0.00% | +200.0% |
| Q4 2020 | $1,196,000 | +252.8% | 104,956 | +178.9% | 0.00% | – |
| Q3 2020 | $339,000 | -78.1% | 37,638 | -74.9% | 0.00% | -100.0% |
| Q2 2020 | $1,547,000 | +38.4% | 149,919 | +35.4% | 0.00% | 0.0% |
| Q1 2020 | $1,118,000 | +2.3% | 110,748 | +35.0% | 0.00% | – |
| Q4 2019 | $1,093,000 | -60.5% | 82,038 | -74.6% | 0.00% | -100.0% |
| Q3 2019 | $2,768,000 | +379.7% | 322,501 | +512.1% | 0.00% | – |
| Q2 2019 | $577,000 | +117.7% | 52,686 | +169.0% | 0.00% | – |
| Q1 2019 | $265,000 | -87.1% | 19,584 | -90.1% | 0.00% | -100.0% |
| Q4 2018 | $2,059,000 | +299.0% | 198,712 | +612.3% | 0.00% | – |
| Q3 2018 | $516,000 | -35.1% | 27,899 | -32.8% | 0.00% | – |
| Q2 2018 | $795,000 | -47.9% | 41,533 | -58.0% | 0.00% | -100.0% |
| Q1 2018 | $1,526,000 | -38.0% | 98,933 | -39.8% | 0.00% | -50.0% |
| Q4 2017 | $2,462,000 | -3.0% | 164,314 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $2,538,000 | -8.4% | 160,828 | +9.6% | 0.00% | 0.0% |
| Q2 2017 | $2,772,000 | +70.5% | 146,784 | +54.0% | 0.00% | +100.0% |
| Q1 2017 | $1,626,000 | -71.4% | 95,324 | -74.4% | 0.00% | -80.0% |
| Q4 2016 | $5,695,000 | +158.5% | 372,490 | +168.4% | 0.01% | +150.0% |
| Q3 2016 | $2,203,000 | +279.2% | 138,786 | +212.1% | 0.00% | +100.0% |
| Q2 2016 | $581,000 | -51.5% | 44,473 | -59.4% | 0.00% | 0.0% |
| Q1 2016 | $1,198,000 | +230.9% | 109,438 | +249.8% | 0.00% | – |
| Q4 2015 | $362,000 | -63.8% | 31,289 | -67.3% | 0.00% | -100.0% |
| Q3 2015 | $999,000 | +117.2% | 95,831 | +151.4% | 0.00% | – |
| Q2 2015 | $460,000 | -37.2% | 38,119 | -16.8% | 0.00% | -100.0% |
| Q1 2015 | $733,000 | -30.3% | 45,822 | -33.2% | 0.00% | 0.0% |
| Q4 2014 | $1,051,000 | +199.4% | 68,591 | +153.3% | 0.00% | – |
| Q3 2014 | $351,000 | -13.8% | 27,075 | +2.0% | 0.00% | – |
| Q2 2014 | $407,000 | -51.6% | 26,544 | -61.1% | 0.00% | -100.0% |
| Q1 2014 | $841,000 | -9.3% | 68,260 | -14.5% | 0.00% | 0.0% |
| Q4 2013 | $927,000 | +17.5% | 79,800 | +19.7% | 0.00% | – |
| Q3 2013 | $789,000 | +2032.4% | 66,663 | +1723.9% | 0.00% | – |
| Q2 2013 | $37,000 | – | 3,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |